Literature DB >> 2887053

New therapy for impotence.

B R Orvis, T F Lue.   

Abstract

In the not too distant past, the physician caring for the impotent patient had few therapeutic options. With the recent advances in penile pharmacotherapy, vascular surgery, and prosthetics, several possibilities for treatment are now available. Before a decision is made, however, numerous factors must be taken into consideration: age, manual dexterity, cause of erectile dysfunction, psychological attitude, and social considerations. Clearly, the choice of therapy for impotence must now be made on an individual basis after a careful diagnostic evaluation and in-depth consultation with the patient. Only then can the treatment that offers the highest likelihood of success, both functional and emotional, be chosen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887053

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  5 in total

1.  "Organic" erection dysfunction: diagnosis and treatment.

Authors:  R W Stevenson
Journal:  Can Fam Physician       Date:  1988-08       Impact factor: 3.275

2.  Corpus cavernosum abscess after Winter procedure performance.

Authors:  Joao Roberto Paladino; Fabio Jose Nascimento; Celso Gromatsky; Antonio Carlos Lima Pompeo
Journal:  BMJ Case Rep       Date:  2014-02-10

3.  Characterization of the genome and serine protease of a novel Bacillus subtilis isolate.

Authors:  Zahoor Khan; Maryam Shafique; Faizan Saleem; M Kamran Azim; Nusrat Jabeen; Sehar Afshan Naz
Journal:  Antonie Van Leeuwenhoek       Date:  2022-01-15       Impact factor: 2.271

Review 4.  An Update on "Reverse Vaccinology": The Pathway from Genomes and Epitope Predictions to Tailored, Recombinant Vaccines.

Authors:  Marcin Michalik; Bardya Djahanschiri; Jack C Leo; Dirk Linke
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Drug-induced priapism. Its aetiology, incidence and treatment.

Authors:  J E Baños; F Bosch; M Farré
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jan-Feb
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.